檢索結果 - Perchenet, Loïc

Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument 由 Mouthon, Luc, Poiraudeau, Serge, Vernon, Margaret, Papadakis, Kelly, Perchenet, Loïc, Khanna, Dinesh

獲取全文 獲取全文 獲取全文

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension 由 Sitbon, Olivier, Cottin, Vincent, Canuet, Matthieu, Clerson, Pierre, Gressin, Virginie, Perchenet, Loïc, Bertoletti, Laurent, Bouvaist, Hélène, Picard, François, Prévot, Grégoire, Bergot, Emmanuel, Simonneau, Gérald

獲取全文 獲取全文 獲取全文

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease... 由 Galiè, Nazzareno, Jansa, Pavel, Pulido, Tomás, Channick, Richard N., Delcroix, Marion, Ghofrani, Hossein-Ardeschir, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Rubin, Lewis J., Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam

獲取全文 獲取全文 獲取全文

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial 由 Souza, Rogério, Channick, Richard N., Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Pulido, Tomás, Sastry, B. K. S., Sitbon, Olivier, Torbicki, Adam, Rubin, Lewis J., Simonneau, Gérald

獲取全文 獲取全文 獲取全文

Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases: Insights From Pulmonary Arterial Hypertension 由 Torbicki, Adam, Bacchi, Marisa, Delcroix, Marion, Farber, Harrison W., Ghofrani, Hossein-Ardeschir, Hennessy, Brian, Jansa, Pavel, Mehta, Sanjay, Perchenet, Loïc, Pulido, Tomas, Rosenberg, Daniel, Rubin, Lewis J., Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Wei, Lee-Jen, Channick, Richard, Benza, Raymond

獲取全文 獲取全文 獲取全文